Why These 3 Health Care Stocks Are Moving Today

Atossa Therapeutics ATOS shares are trading lower on Thursday after the company priced its $14 million registered direct offering at $1 per share.

Atossa Therapeutics focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

Atossa Therapeutics shares were trading down 9.90% at 86 cents Thursday. The stock has a 52-week high of $5.08 and a 52-week low of 76 cents.

Usana Health Sciences USNA shares are trading higher after Roth Capital initiated coverage on the stock with a Buy rating and announced a price target of $107 per share.

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling.

Usana Health Sciences shares were trading up 0.37% at $78.71. The stock has a 52-week high of $92.26 and a 52-week low of $43.01.

Halozyme Therapeutics HALO shares are trading higher after Berenberg initiated coverage on the stock with a Buy rating and announced a price target of $50 per share.

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors.

Halozyme Therapeutics shares were trading up 2.10% at $41.98. The stock has a 52-week high of $44.53 and a 52-week low of $12.71.